Pharmocotherapy Principles and Practice - Tuberculosis
Contact Hours: 1.0
ACPE No: 014-999-07-087-H04
Activity Type:
Release Date:
Expiration Date:
Learning Objectives
Upon completion of this activity the participant should be able to:
On completion of the chapter, the reader will be able to
1. Compare the risk for active tuberculosis disease among patients based on their age, immune status, place of birth, and time since exposure to an active case.
2. Design, evaluate, and assess an appropriate therapeutic plan for an immunocompetent, immunocompromised, pregnant, and pediatric patient.
3. Assess the effectiveness of therapy in tuberculosis patients.
4. Cite the names of the tuberculosis drugs most likely to cause hepatotoxicity.
5. Select patients for whom therapeutic drug monitoring may be valuable.
6. Design, evaluate, and assess appropriate regimens for the treatment of latent tunerculosis infection (LTBI) in all patient populations.
7. Identify the necessary laboratory monitoring parameters for patients on antituberculosis medications.
8. Design a therapeutic plan for a patient with tuberculosis meningitis or tunerculosis osteomyelitis.
Faculty:
Computer Requirements for Online Courses
PC
- Windows 2000 SE or greater
- Flash Player Plugin 9.0 or later
- Internet Explorer 6.0 or later OR Firefox 2.0 or later
- Sound Card & Speakers
- 800 x 600 Minimum Monitor Resolution (1024 x 768 Recommended)
- Adobe Acrobat Reader for viewing PDF's
MAC
- Mac OS 10.2.8
- Flash Player Plugin 9.0 or greater
- Safari 2.0 or above OR Firefox 2.0 or later
- Sound Card & Speakers
- 800 x 600 Minimum Monitor Resolution (1024 x 768 Recommended)
- Adobe Acrobat Reader for viewing PDF's'
The University of Georgia College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.